Federated Hermes, Inc. Albireo Pharma, Inc. Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$18.01 - $23.78 $5.43 Million - $7.17 Million	-301,636 Reduced 13.36%	1,956,488 $42.3 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $48,960 - $79,110	3,000 Added 0.13%	2,258,124 $43.7 Million
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $1.92 Million - $3.86 Million	-103,500 Reduced 4.39%	2,255,124 $44.8 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $40,261 - $59,451	-1,900 Reduced 0.08%	2,358,624 $54.9 Million
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $14,610 - $19,213	-534 Reduced 0.02%	2,360,524 $73.6 Million
Q1 2021 May 13, 2021	SELL	$32.03 - $42.85 $2.75 Million - $3.68 Million	-85,942 Reduced 3.51%	2,361,058 $83.2 Million
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $1.01 Million - $1.35 Million	32,100 Added 1.33%	2,447,000 $91.8 Million
Q3 2020 Nov 12, 2020	BUY	$23.19 - $41.61 $11.6 Million - $20.9 Million	501,710 Added 26.22%	2,414,900 $80.6 Million
Q1 2020 May 13, 2020	BUY	$11.67 - $27.23 $5.56 Million - $13 Million	476,190 Added 33.14%	1,913,190 $31.3 Million
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $22 Million - $27.2 Million	717,405 Added 99.7%	1,437,000 $46.3 Million
Q1 2019 May 10, 2019	BUY	$22.22 - $32.21 $2.97 Million - $4.3 Million	133,449 Added 22.77%	719,595 $23.2 Million
Q4 2018 Feb 13, 2019	SELL	$20.9 - $32.57 $1,274 - $1,986	-61 Reduced 0.01%	586,146 $14.4 Million
Q3 2018 Nov 13, 2018	BUY	$29.29 - $36.87 $1,786 - $2,249	61 Added 0.01%	586,207 $19.3 Million
Q2 2018 Aug 10, 2018	BUY	$28.9 - $37.31 $7.98 Million - $10.3 Million	276,221 Added 89.13%	586,146 $20.8 Million
Q1 2018 May 09, 2018	BUY	$26.78 - $39.35 $8.3 Million - $12.2 Million	309,925 New	309,925 $10.1 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account